Search alternatives:
significant gender » significant concern (Expand Search), significant burden (Expand Search)
linear decrease » linear increase (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 341 - 360 results of 1,734 for search '(( significantly ((linear decrease) OR (nn decrease)) ) OR ( significant gender decrease ))', query time: 0.39s Refine Results
  1. 341
    Absolute and relative overall CVD DALYs rate attributable to 1<sup>st</sup>-level risk factors in Chile.

    Absolute and relative overall CVD DALYs rate attributable to 1<sup>st</sup>-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 342
    Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 343
    Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile.

    Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 344
    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).

    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 345
    Complication subgroup analysis of the RAAS system in T2DM patients.

    Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 346
    Flow diagram of patient selection and subgroup classification.

    Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 347
    The values of angiotensin II

    The values of angiotensin II by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 348
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 349
    General characterization of T2DM patients and healthy controls.

    General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 350
    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups.

    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 351
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 352
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 353
    Survey-weighted association of flavonoids and six subclasses intake with MASLD.

    Survey-weighted association of flavonoids and six subclasses intake with MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 354
    Survey-weighted baseline characteristic of the study population by MASLD.

    Survey-weighted baseline characteristic of the study population by MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 355
    Weighted Quantile Sum model regression index weights for the MASLD.

    Weighted Quantile Sum model regression index weights for the MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 356
    Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex, race/ethnicity, education level and poverty-income ratio, BMI, diabetes, smoking status and drinking status.

    Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex,... by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 357
    The flowchart of the sample selection from NHANES 2007-2010, 2017-2018.

    The flowchart of the sample selection from NHANES 2007-2010, 2017-2018. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 358
    nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU.

    nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

    Published 2025
    Save to List
    Saved in:
  19. 359
    Fig 5 -

    Fig 5 - by Torsten Schober (20485754)

    Published 2024
    Save to List
    Saved in:
  20. 360
    Fig 4 -

    Fig 4 - by Torsten Schober (20485754)

    Published 2024
    Save to List
    Saved in:

Search Tools: